Simulative and experimental investigation on the cleavage site that generates the soluble human LOX-1-Reference-Cited by-同舟云学术

Simulative and experimental investigation on the cleavage site that generates the soluble human LOX-1

Published:2013-12 Issue:1-2 Volume:540 Page:9-18
ISSN:0003-9861
Container-title:Archives of Biochemistry and Biophysics
language:en
Short-container-title:Archives of Biochemistry and Biophysics

Author:

Biocca Silvia,Arcangeli Tania,Tagliaferri Elisa,Testa Barbara,Vindigni Giulia,Oteri Francesco,Giorgi Alessandra,Iacovelli Federico,Novelli Giuseppe,Desideri Alessandro,Falconi Mattia

Funder

CASPUR research center of Rome, Italy (Inter Universities Consortium for Supercomputing Applications)

Development of innovative molecules in the atherosclerosis treatment having as molecular target the LOX-1 receptor

TECNO.TIB.E.R.I.S. (Consorzio Tecnologie Tiburtino per l’Eccellenza nella Ricerca, l’Innovazione e lo Sviluppo Industriale)

MOLBLOX

Publisher

Elsevier BV

Subject

Molecular Biology,Biochemistry,Biophysics

Reference61 articles.

1. The LOX-1 Scavenger Receptor and Its Implications in the Treatment of Vascular Disease

2. The Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 and its Soluble Form: Cardiovascular Implications

3. An endothelial receptor for oxidized low-density lipoprotein

4. Oxidized Low-Density Lipoprotein and Atherosclerosis Implications in Antioxidant Therapy

5. The Discovery of LOX-1, its Ligands and Clinical Significance

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radical Oxygen Species, Oxidized Low-Density Lipoproteins, and Lectin-like Oxidized Low-Density Lipoprotein Receptor 1: A Vicious Circle in Atherosclerotic Process;Antioxidants;2024-05-09

2. Relationship of Soluble Lectin‐Like Low‐Density Lipoprotein Receptor‐1 (sLOX‐1) With Inflammation and Coronary Plaque Progression in Psoriasis;Journal of the American Heart Association;2023-11-21

3. Computational and experimental validation of phthalocyanine and hypericin as effective SARS-CoV-2 fusion inhibitors;Journal of Biomolecular Structure and Dynamics;2023-05-26

4. The structural basis of effective LOX-1 inhibition;Future Medicinal Chemistry;2022-05

5. Proteolytic Regulation of the Lectin-Like Oxidized Lipoprotein Receptor LOX-1;Frontiers in Cardiovascular Medicine;2021-01-20